Meta-analysis of Clinical Effectiveness of Anticonvulsants for Full Term Newborns with Perinatal Asphyxia

陈燕琳,周文浩

DOI: https://doi.org/10.3969/j.issn.1673-5501.2009.01.007

2009-01-01

Abstract:Objective The aim of this study was to evaluate the studies of anticonvulsants in the management of neonatal perinatal asphyxia by performing a systematic review of the literature with a meta-analysis method. In order to assess the clinical effectiveness of anticonvulsants for neonatal perinatal asphyxia, discussed the possibility of the anticonvulsants treatment for perinatal asphyxia.Methods PubMed, EMBASE, Ovid, Springer and CNKI databases were searched in two languages(English and Chinese) by using the anticonvulsants, term infants and perinatal asphyxia for human clinical trials, including unpublished documents from scientific meetings and theses, and the similar documents listed in the reference of above documents were also included. All randomised or quasi-randomised controlled clinical trials that reported data comparing the following outcomes: mortality, neurodevelopmental disability, neonatal seizures and adverse events, following anticonvulsant therapy in term infants compared to controls (with or without placebo) following perinatal asphyxia. Results According to inclusion and exclusion criteria,five randomized or quasi-randomised controlled trials were included,which quality grades were C in 4 RCTs and B in 1 RCT.The results of meta analysis showed there was no significant on mortality compared anticonvulsant therapy group with controls(RR=1.13,95%CI:0.59-2.17).There was also no significance on severe neurodevelopmental disability(RR=0.61,95%CI:0.30-1.22),death and severe neurodevelopmental disability(RR=0.65,95%CI:0.30-1.41) and neonatal seizures(RR=0.76,95%CI:0.45-1.31) .Conclusions Anticonvulsant therapy to term infants following perinatal asphyxia cannot be recommended for routine clinical practice now.Any future studies should be of high quality, randomised control trials,sufficient size, with minimal attrition,to have the power to confirm clinically important reductions in mortality and severe neurodevelopmental disability.